Perrigo Company Plc Ireland (PRGO) Actualités

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Perrigo Provides Detailed Plan to Consumerize, Simplify and Scale its Unique Global Self-Care Platform at its Virtual Investor Day

Perrigo Provides Detailed Plan to Consumerize, Simplify and Scale its Unique Global Self-Care Platform at its...

Form 8-K - Current report

Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations

Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations PR...

Form 8-K - Current report

Perrigo to Attend the UBS 2025 Global Consumer and Retail Conference

Perrigo to Attend the UBS 2025 Global Consumer and Retail Conference PR Newswire DUBLIN, Feb. 26, 2025 DUBLIN...

Perrigo Increases Quarterly Dividend by 5%

Perrigo Increases Quarterly Dividend by 5% PR Newswire DUBLIN, Feb. 19, 2025 DUBLIN, Feb. 19, 2025...

Form 3 - Initial statement of beneficial ownership of securities

Opill® extends mission of breaking down birth control barriers with launch of multi-state college tour and expansion of partnerships

Opill® extends mission of breaking down birth control barriers with launch of multi-state college tour and...

Perrigo to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025, Host Virtual Investor Day on February 28, 2025

Perrigo to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025, Host Virtual...

Form 8-K - Current report

Perrigo Expands its Scientific Office; Appoints Abbie Lennox as Executive Vice President and Chief Scientific Officer

Perrigo Expands its Scientific Office; Appoints Abbie Lennox as Executive Vice President and Chief Scientific...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K/A - Current report: [Amend]